Kervio Gaëlle, Ville Nathalie S, Leclercq Christophe, Daubert Jean-Claude, Carre François
Groupe de Recherche Cardiovasculaire, Université de Rennes, France.
Eur J Cardiovasc Prev Rehabil. 2004 Apr;11(2):171-7. doi: 10.1097/01.hjr.0000119964.42813.98.
The six-minute walk test (6-MWT) is widely used to assess exercise tolerance in chronic heart failure patients (CHF). The aim of this study was to analyse cardiorespiratory parameters kinetics during the 6-MWT in CHF and in healthy subjects.
A treadmill, symptom-limited exercise test and a 6-MWT were performed by 14 CHF under optimal drug treatment (CHFD), 17 CHF with cardiac resynchronization (CHFP), and 12 healthy subjects. Cardiorespiratory responses were assessed by a validated portable system.
All subjects exceeded their ventilatory threshold during the 6-MWT. Healthy subjects and CHF performed the 6-MWT around 75 and 90% of peak oxygen uptake (V'O2) respectively (P<0.001). In CHF, a steady state was observed only for walking speed and V'O2, with a slight delay in comparison with healthy subjects, for whom a steady state was also observed for carbon dioxide production and ventilation (V'E). During the 6-MWT, the V'E adaptation was due mainly to an increase in tidal volume (VT) in CHFD, whereas in CHFP, it was due to a similar increase in VT and breathing frequency (f). In these patients, the 6-MWT VT/f slope was lower than in CHFD (P<0.01).
During the 6-MWT, the V'O2 steady state is slightly delayed in CHF, which could be related partly to their higher exercise intensity. Moreover, each CHF group is characterized by a specific ventilation components response during the 6-MWT.
六分钟步行试验(6-MWT)被广泛用于评估慢性心力衰竭患者(CHF)的运动耐力。本研究的目的是分析CHF患者和健康受试者在6-MWT期间心肺参数的动力学变化。
对14例接受最佳药物治疗的CHF患者(CHFD组)、17例接受心脏再同步治疗的CHF患者(CHFP组)和12名健康受试者进行了跑步机症状限制性运动试验和6-MWT。通过经过验证的便携式系统评估心肺反应。
所有受试者在6-MWT期间均超过了通气阈值。健康受试者和CHF患者进行6-MWT时分别达到峰值摄氧量(V'O2)的75%和90%左右(P<0.001)。在CHF患者中,仅观察到步行速度和V'O2达到稳定状态,与健康受试者相比略有延迟,健康受试者的二氧化碳产生量和通气量(V'E)也达到稳定状态。在6-MWT期间,CHFD组V'E的适应性主要归因于潮气量(VT)增加,而CHFP组则归因于VT和呼吸频率(f)的类似增加。在这些患者中,6-MWT的VT/f斜率低于CHFD组(P<0.01)。
在6-MWT期间,CHF患者的V'O2稳定状态略有延迟,这可能部分与其较高的运动强度有关。此外,每个CHF组在6-MWT期间都有特定的通气成分反应特征。